cyclopentane has been researched along with Canine Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Assumpção, ALFV; Huelsmeyer, MK; Jia, S; Lu, Z; Pan, X; Vail, DM; Van Hesteren, MA; Wood, EA | 1 |
| Assumpção, ALFV; Lu, Z; Marlowe, KW; Pan, X; Shaffer, KS | 1 |
| Baker, GG; Carter, JD; Prasse, KW | 1 |
3 other study(ies) available for cyclopentane and Canine Diseases
| Article | Year |
|---|---|
Pevonedistat targeted therapy inhibits canine melanoma cell growth through induction of DNA re-replication and senescence.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclopentanes; DNA Replication; Dog Diseases; Dogs; Enzyme Inhibitors; Melanoma; Mouth Neoplasms; Pyrimidines | 2020 |
Targeting NEDD8-activating enzyme is a new approach to treat canine diffuse large B-cell lymphoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred NOD; NEDD8 Protein; Neoplasm Transplantation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Ubiquitin-Activating Enzymes | 2018 |
Ocular and clinical features of canine thrombocytopenic purpura (a case report).
Topics: Animals; Blindness; Cyclopentanes; Dog Diseases; Dogs; Female; Hyphema; Pilocarpine; Purpura, Thrombocytopenic; Salicylates | 1971 |